Valid Member
11/7/2009
1-877-484-2472
Monday-Thursday, 6am to 8pm, • Friday, 6am to 7pm
Ship To:
United States
| Other Countries
Utah residents only: We are unable to ship to the state of Utah. We apologize for any inconvenience.
Up until 2003, Viagra dominated the ED (Erectile Dysfunction) market as the only available oral therapy with which to treat ED in impotent adult males. However, while Viagra worked for most people, there were some that it failed to help, and others who it only helped so much. In some cases of illness-related impotency, Viagra showed little or no results in patients. Levitra offered a light at the end of the tunnel for those who had already tried taking Viagra and were still unable to achieve or maintain an erection. Since its release to the public, Levitra has been known to work for many ED patients when other forms of ED treatment have not.
Your physician will recommend the proper dosage for you based upon your medical history and your specific situation, as every person’s situation is unique. The typical starting dosage of Levitra is 10-mg, but your doctor may raise or lower that based upon your health. Levitra comes in 2.5-mg, 5-mg, 10-mg, and 20-mg tablets and is intended to only be taken orally, as directed by your physician.
In clinical studies, which were conducted with usage of a placebo, Levitra was shown to be more than 80% effective for patients who reported a more sustained and firmer erection, which usually lasted through their intimate sessions. While Levitra will work for most people, it may not work the same for everybody. Always consult with your physician as to which of the ED drugs they think will work best for you, and your specific situation.
Schering-Plough & Glaxo SmithKline just announced that Cramer-Krasselt, the online marketing firm known best for its campaign with Rozerem, has been awarded the digital side of the viral marketing campaign for Levitra. The drug currently is the third most prescribed ED (Erectile Dysfunction) drug on the market behind Cialis (#2) and Viagra (#1). Schering-Plough & Glaxo SmithKline hope that the new digital campaign will drive up their sales numbers and place Levitra higher up on the tier of most used ED drugs.
Trademarks and registered marks are the properties of their respective companies.
Copyright © 1998-2009 Viamedic. All Rights Reserved.
